These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38250857)

  • 1. Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain.
    Nomah DK; Reyes-Urueña J; Alonso L; Díaz Y; Moreno-Fornés S; Aceiton J; Bruguera A; Martín-Iguacel R; Imaz A; Gutierrez MDM; Román RW; Suanzes P; Ambrosioni J; Casabona J; Miro JM; Llibre JM; The Piscis Study Group
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infections post-vaccination by HIV status in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon K; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg M; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    medRxiv; 2021 Dec; ():. PubMed ID: 34909791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis.
    Nomah DK; Díaz Y; Bruguera A; Moreno-Fornés S; Aceiton J; Reyes-Urueña J; Llibre JM; Falcó V; Imaz A; Fanjul FJ; Peraire J; Deig E; Domingo P; Inciarte A; Casabona J; Miró JM
    Open Forum Infect Dis; 2024 Jan; 11(1):ofad693. PubMed ID: 38221982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV.
    Hechter RC; Qian L; Liu IA; Sy LS; Ryan DS; Xu S; Williams JTB; Klein NP; Kaiser RM; Liles EG; Glanz JM; Jackson LA; Sundaram ME; Weintraub ES; Tseng HF
    JAMA Netw Open; 2024 Jun; 7(6):e2415220. PubMed ID: 38842808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
    Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
    AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Vaccination Uptake and Associated Factors Among Adults With and Without Human Immunodeficiency Virus in a Large, Integrated Healthcare System.
    Imp BM; Levine T; Satre DD; Skarbinski J; Luu MN; Sterling SA; Silverberg MJ
    Clin Infect Dis; 2023 Jul; 77(1):56-63. PubMed ID: 36857440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
    Monge S; Rojas-Benedicto A; Olmedo C; Mazagatos C; José Sierra M; Limia A; Martín-Merino E; Larrauri A; Hernán MA;
    Lancet Infect Dis; 2022 Sep; 22(9):1313-1320. PubMed ID: 35658998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
    Hassold N; Brichler S; Ouedraogo E; Leclerc D; Carroue S; Gater Y; Alloui C; Carbonnelle E; Bouchaud O; Mechai F; Cordel H; Delagreverie H
    AIDS; 2022 Mar; 36(4):F1-F5. PubMed ID: 35013085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).
    Tuan JJ; Zapata H; Barakat L; Andrews L; Behnegar A; Kim YW; Kayani J; Mutic S; Ryall L; Turcotte B; Critch-Gilfillan T; Zhao M; Salahuddin S; Gupta S; Sutton R; Friedland G; Emu B; Ogbuagu O
    BMC Infect Dis; 2022 Sep; 22(1):744. PubMed ID: 36131232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
    Verburgh ML; van Pul L; Grobben M; Boyd A; Wit FWNM; van Nuenen AC; van Dort KA; Tejjani K; van Rijswijk J; Bakker M; van der Hoek L; Schim van der Loeff MF; van der Valk M; van Gils MJ; Kootstra NA; Reiss P
    Microbiol Spectr; 2023 Jun; 11(3):e0115523. PubMed ID: 37166335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Lea AN; Leyden WA; Sofrygin O; Marafino BJ; Skarbinski J; Napravnik S; Agil D; Augenbraun M; Benning L; Horberg MA; Jefferson C; Marconi VC; Park LS; Gordon KS; Bastarache L; Gangireddy S; Althoff KN; Coburn SB; Gebo KA; Lang R; Williams C; Silverberg MJ
    Clin Infect Dis; 2023 May; 76(10):1727-1734. PubMed ID: 36861341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration.
    Soyer EM; McGinnis KA; Justice AC; Hsieh E; Rodriguez-Barradas MC; Williams EC; Park LS
    AIDS Behav; 2024 Nov; 28(11):3605-3614. PubMed ID: 39046612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
    Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Geers D; Schmitz KS; Garcia Garrido HM; Koopmans MPG; Dalm VASH; Kootstra NA; Huckriede ALW; Lafeber M; van Baarle D; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
    N Engl J Med; 2022 Mar; 386(10):951-963. PubMed ID: 35045226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV.
    Nomah DK; Llibre JM; Díaz Y; Moreno S; Aceiton J; Bruguera A; Gutiérrez-Macià M; Imaz A; Suanzes P; Navarro G; Orti A; Miro JM; Casabona J; Reyes-Urueña J; The Piscis Study Group
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.
    Sauré D; O'Ryan M; Torres JP; Zuñiga M; Soto-Rifo R; Valiente-Echeverría F; Gaete-Argel A; Neira I; Saavedra V; Acevedo ML; Archila C; Acuña F; Rain M; Basso LJ
    Lancet Microbe; 2023 Mar; 4(3):e149-e158. PubMed ID: 36716754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination.
    Jongkees MJ; Geers D; Hensley KS; Huisman W; GeurtsvanKessel CH; Bogers S; Gommers L; Papageorgiou G; Jochems SP; den Hollander JG; Schippers EF; Ammerlaan HSM; Bierman WFW; van der Valk M; Berrevoets MAH; Soetekouw R; Langebeek N; Bruns AHW; Leyten EMS; Sigaloff KCE; van Vonderen MGA; Delsing CE; Branger J; Katsikis PD; Mueller YM; de Vries RD; Rijnders BJA; Brinkman K; Rokx C; Roukens AHE
    J Infect Dis; 2023 Mar; 227(5):651-662. PubMed ID: 36402141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.